Appleton Partners Inc. MA Sells 1,385 Shares of Colgate-Palmolive Company $CL

Appleton Partners Inc. MA reduced its position in Colgate-Palmolive Company (NYSE:CL) by 24.4% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,281 shares of the company’s stock after selling 1,385 shares during the period. Appleton Partners Inc. MA’s holdings in Colgate-Palmolive were worth $389,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of CL. Personal CFO Solutions LLC acquired a new position in Colgate-Palmolive during the 1st quarter valued at approximately $285,000. Vision Capital Management Inc. acquired a new position in shares of Colgate-Palmolive in the 1st quarter valued at $322,000. Autumn Glory Partners LLC raised its stake in Colgate-Palmolive by 67.4% in the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company’s stock worth $851,000 after acquiring an additional 3,586 shares during the last quarter. Financial Gravity Asset Management Inc. acquired a new stake in Colgate-Palmolive during the 1st quarter worth about $2,166,000. Finally, Penserra Capital Management LLC grew its stake in Colgate-Palmolive by 398.6% during the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock valued at $997,000 after purchasing an additional 8,515 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE CL opened at $77.39 on Tuesday. The stock has a market capitalization of $62.55 billion, a price-to-earnings ratio of 21.74, a PEG ratio of 4.06 and a beta of 0.34. The stock has a 50-day moving average of $83.11 and a 200 day moving average of $88.21. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a twelve month low of $77.32 and a twelve month high of $102.61.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the previous year, the business earned $0.91 earnings per share. The business’s revenue was up 1.0% compared to the same quarter last year. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.43%.

Analysts Set New Price Targets

A number of research firms recently commented on CL. UBS Group decreased their target price on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a report on Thursday, July 17th. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Friday. They issued a “neutral” rating and a $84.00 price objective on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Saturday, September 27th. Citigroup lowered their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, August 4th. Finally, Morgan Stanley cut their price target on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $94.83.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.